Superworth

Seer EPS SEER

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$1.22
Latest quarter, Q2 FY26
−$0.31
Fiscal year 2025
−$1.28

Seer's earnings per share was −$1.22 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.31.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.28n/a
FY2024−$1.39n/a
FY2023−$1.36n/a
FY2022−$1.49n/a
FY2021−$1.16n/a
FY2020−$2.59n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.31n/a−$1.22
Q1 FY26−$0.30n/a−$1.24
Q4 FY25−$0.29n/a−$1.28
Q3 FY25−$0.32n/a−$1.36
Q2 FY25−$0.33n/a−$1.39
Q1 FY25−$0.34n/a−$1.41
Q4 FY24−$0.37n/a−$1.39
Q3 FY24−$0.35n/a−$1.30
Q2 FY24−$0.35n/a−$1.28
Q1 FY24−$0.32n/a−$1.30
Q4 FY23−$0.28n/a−$1.36
Q3 FY23−$0.33n/a−$1.44

Against its peers

Companies in Healthcare nearest Seer's size, closest first, today.

CompanyEPS, 12 monthsGrowth
SEERSeer−$1.22
KEQUKewaunee Scientific$2.76−33% a year
ICCCImmucell$0.08−58% a year
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
APTAlpha Pro Tech$0.41+24% a year
NATRNatures Sunshine Products$1.01+36% a year
ELMDElectromed$1.31+56% a year
UTMDUtah Medical Products$3.28−12% a year
Peer median$0.71

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Seer

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.